Home Supplements That Start With N Nordihydroguaiaretic acid cognitive health and antioxidant benefits, dosage, and safety explained

Nordihydroguaiaretic acid cognitive health and antioxidant benefits, dosage, and safety explained

By
Vita Library
-
104

Nordihydroguaiaretic acid (NDGA) is a plant-derived compound that has attracted attention for its strong antioxidant and anti-inflammatory actions and its ability to influence many cellular pathways. It is a lignan found mainly in the creosote bush (Larrea tridentata), a shrub used in traditional North American herbal medicine. In laboratory and animal studies, NDGA has shown potential in areas such as cancer biology, metabolic health, neuroprotection, aging, and viral infections.

At the same time, NDGA has a long and well-documented history of toxicity, especially to the liver and kidneys. It was once used as a food preservative but was phased out when serious safety concerns emerged. Today, NDGA is studied mostly as an experimental molecule or as the backbone for safer derivatives, not as a routine dietary supplement.

This guide explains what NDGA is, how it works, what research suggests about its potential benefits, and—crucially—why safety concerns mean it should not be used casually or without medical oversight.

Nordihydroguaiaretic acid key insights

  • NDGA is a powerful plant lignan from creosote bush with strong antioxidant and enzyme-inhibiting properties that affect many cellular pathways.
  • Experimental models suggest NDGA may influence cancer growth, metabolic health, neurodegeneration, viral infections, and lifespan, but human evidence is limited and mixed.
  • Serious liver and kidney toxicity have been linked to NDGA exposure and NDGA-containing herbal products, including cases of organ failure.
  • In clinical oncology studies, oral NDGA doses typically ranged from about 250 mg/day up to around 2,000 mg/day under close medical supervision; no generally safe daily dose has been established for self-directed use.
  • People with any liver or kidney disease, those taking hepatotoxic or nephrotoxic drugs, pregnant or breastfeeding individuals, and anyone outside a formal clinical trial should avoid NDGA.

Table of Contents

What is nordihydroguaiaretic acid?

Nordihydroguaiaretic acid (NDGA) is a small polyphenolic lignan molecule originally isolated from the creosote bush, Larrea tridentata. This desert shrub grows in the southwestern United States and northern Mexico and has been used in traditional medicine for a variety of ailments. NDGA is one of its main bioactive constituents and is present in high concentrations in the leaves and twigs.

Chemically, NDGA is a catechol-type compound with four phenolic hydroxyl groups. This structure allows it to donate electrons and neutralize reactive oxygen species, which underlies its strong antioxidant capacity. It is also highly lipophilic, meaning it partitions into cell membranes and lipid-rich environments, where it can influence membrane-bound enzymes and signaling pathways.

Historically, NDGA was used industrially as an antioxidant in fats and oils because it can delay rancidity. It was also explored as a stabilizer in other products that are sensitive to oxidation. However, long-term animal studies revealed kidney lesions and cystic changes, and later observations in humans linked NDGA-containing herbal preparations with serious side effects. As a result, NDGA was withdrawn as a food additive and is not approved as a routine preservative or dietary supplement in many jurisdictions.

In pharmacology, NDGA has served as a lead compound for the development of derivatives intended to retain beneficial activity while reducing toxicity. One such derivative, terameprocol (also known as M4N or masoprocol), has been studied in oncology, including topical treatment for actinic keratoses and systemic administration for certain cancers. NDGA itself has been used in early-phase clinical research, but safety concerns remain a major limitation for long-term or preventive use.

Today, NDGA is best understood as an experimental bioactive molecule with powerful effects—not a routine supplement to add to a daily regimen.

Back to top ↑

How nordihydroguaiaretic acid works in the body

NDGA is pharmacologically “busy”: it interacts with several important cellular targets, which explains both its broad range of experimental benefits and its potential for harm.

One of NDGA’s best-known actions is inhibition of lipoxygenases, enzymes that convert arachidonic acid into leukotrienes and other lipid mediators involved in inflammation and allergy. By inhibiting 5-lipoxygenase and related enzymes, NDGA can reduce the production of pro-inflammatory mediators, which may contribute to its effects in inflammatory and allergic models.

NDGA is also a potent antioxidant. In biochemical systems, it scavenges a variety of reactive species, including hydroxyl radical, peroxynitrite, superoxide, and singlet oxygen. In cell and animal models, it can modulate the Nrf2/ARE pathway, a central regulator of antioxidant defenses. Enhanced Nrf2 activity increases the expression of detoxifying and cytoprotective enzymes, which may help cells cope with oxidative stress in conditions such as ischemia, neurodegeneration, or chronic inflammation.

More recently, NDGA has been shown to directly inhibit the histone acetyltransferase p300, an epigenetic regulator that controls acetylation of histones and many non-histone proteins. By inhibiting p300, NDGA can reduce certain acetylation marks associated with aging and activate autophagy, the process by which cells recycle damaged components. In animal models, this p300 inhibition and associated increase in autophagic flux are linked to lifespan extension and improved cellular resilience.

Beyond these pathways, NDGA interacts with several signaling systems relevant to cancer and metabolism. It can inhibit insulin-like growth factor 1 receptor (IGF-1R) and HER2 signaling in tumor cells, influence glucose transport, and affect cell cycle regulators such as p21. These actions may explain its antiproliferative effects seen in certain cancer cell lines and animal tumor models.

The downside of this pleiotropy is that NDGA does not act with narrow specificity. The same redox and signaling changes that are beneficial at certain doses and contexts may become harmful at higher exposures or over long periods. NDGA can also undergo oxidation to reactive quinone-type metabolites that may bind to cellular macromolecules and contribute to toxicity, particularly in the liver and kidneys.

In short, NDGA affects inflammation, oxidative stress, epigenetic regulation, growth signaling, and cellular housekeeping—all powerful levers in biology that require careful control.

Back to top ↑

Potential benefits and experimental uses

Most of what is known about NDGA’s “benefits” comes from preclinical research—cell cultures, animal models, and mechanistic studies. These findings are intriguing but should not be translated directly into advice for human supplementation.

Aging and longevity
In the National Institute on Aging’s Interventions Testing Program, NDGA extended median lifespan in mice, particularly in males. Follow-up work showed NDGA can increase lifespan in evolutionarily distant organisms such as fruit flies and mosquitoes. Mechanistic studies indicate that NDGA’s inhibition of p300 and activation of autophagy likely contribute to these effects. In treated animals, investigators observed changes in histone acetylation, improved muscle function in old mice, and increased autophagic flux.

However, NDGA-treated mice also showed an increased incidence of certain tumors and bleeding complications in some studies, underscoring the complexity of targeting aging pathways with a compound that has its own toxicity risks.

Cancer biology
NDGA and its derivatives have been widely studied in cancer models. In vitro, NDGA can inhibit proliferation and induce apoptosis in diverse tumor cell lines, including breast, prostate, cervical, and glioma cells. Mechanisms include inhibition of IGF-1R and HER2 signaling, interference with lipoxygenase pathways, cell cycle arrest, and modulation of transcription factors linked to growth and survival. Several NDGA-derived molecules, such as terameprocol, have been developed specifically as anticancer agents and have entered early-phase clinical trials.

In humans, small pilot studies in prostate cancer have explored NDGA as an oral agent, with doses up to around 2,000 mg/day. These studies observed biological effects on hormone and prostate-specific antigen markers but did not establish long-term efficacy, and safety concerns limit broader development.

Metabolic and cardiovascular models
In animal models of type 2 diabetes and metabolic syndrome, NDGA has been reported to improve some markers of insulin sensitivity, lipid metabolism, and inflammation. It can modulate enzymes related to glucose regulation and may influence blood pressure and vascular function via lipoxygenase pathways. These findings are still at an experimental stage, and NDGA is not an approved therapy for metabolic disorders.

Neuroprotection and other areas
NDGA has shown protective effects in models of neurodegenerative disease, such as Huntington’s disease and amyotrophic lateral sclerosis, and in ischemic brain injury, likely through antioxidant and signaling mechanisms. It also exhibits antiviral activity against certain flaviviruses and can modulate immune responses in infection models.

Despite this broad experimental profile, there is no strong evidence from large, well-controlled human trials that NDGA safely improves cognitive function, metabolic health, or cancer outcomes when used as a supplement. The gap between preclinical promise and clinical reality is widened by its toxicity profile.

Back to top ↑

Safety concerns and toxicity profile

Among all aspects of NDGA, safety is the most important for practical decision-making. NDGA’s toxicity has been clearly demonstrated in animal studies and supported by human case reports.

Kidney toxicity and cystic disease
Long-term feeding studies in rats showed that dietary NDGA at moderate percentages of the diet for many weeks caused cystic nephropathy, with vacuolation of kidney tubule cells and progressive cyst formation. These changes were associated with altered kidney function and histologic damage. Follow-up work demonstrated that NDGA-induced renal cysts can be exacerbated by additional stressors, highlighting a susceptibility of the kidney to this compound.

Liver injury
NDGA-containing herbal preparations, particularly chaparral (creosote bush) supplements, have been linked to cases of acute and sometimes severe hepatitis in humans. Patients have presented with jaundice, markedly elevated liver enzymes, and liver biopsy findings ranging from cholestatic hepatitis to extensive necrosis. In some reports, the injury progressed to liver failure requiring transplantation. Because NDGA is a major active component of chaparral, it is considered a key contributor to this hepatotoxicity, although other plant constituents may also play roles.

Animal studies mirror these findings: NDGA can cause centrilobular hepatic necrosis, oxidative stress, and mitochondrial dysfunction in the liver at doses not far above those that produce pharmacological effects. Differences in species, dosing schedule, and metabolic capacity make it difficult to define a clearly safe exposure level for humans.

Other toxicities and paradoxical effects
NDGA’s strong antioxidant action is coupled with the potential for pro-oxidant behavior under certain conditions. Its catechol groups can oxidize to quinone structures that may react with proteins and DNA, potentially contributing to cellular damage. Some research describes paradoxical effects where NDGA appears protective at lower concentrations but harmful at higher ones, including increased oxidative stress, DNA damage, or interference with cell survival pathways.

In rodent lifespan studies, NDGA extended median lifespan but was associated with increased incidence of some malignancies and bleeding tendencies, suggesting that even when overall survival improves in a controlled setting, there may be trade-offs in disease patterns.

Given these findings, regulatory agencies and expert reviews generally do not consider NDGA safe as a routine additive or supplement. When NDGA or its derivatives are used clinically, it is typically within tightly controlled trials that include regular monitoring of liver and kidney function and careful dose adjustments.

Back to top ↑

Dosage, forms, and who should avoid it

Unlike vitamins or common herbal extracts, NDGA does not have a recognized safe supplemental dose for the general population. Any numbers discussed in the literature reflect experimental use, not recommendations for self-directed intake.

Forms you may encounter
NDGA can appear in several contexts:

  • As a purified compound in research settings.
  • As part of NDGA-based drug candidates such as terameprocol or other derivatives.
  • Indirectly, within herbal products made from creosote bush (chaparral), which naturally contains NDGA.

Many reputable supplement manufacturers have removed chaparral-containing products or label them with strong warnings because of liver and kidney risk.

Doses in research settings
In human oncology studies, NDGA has been administered orally at doses ranging roughly from 250 mg/day up to about 2,000 mg/day, divided across the day, under close medical supervision. Participants were carefully selected and monitored with regular blood tests and clinical evaluations. Even in this context, concerns about elevations in liver enzymes, gastrointestinal side effects, and other adverse events have limited enthusiasm for long-term treatment.

Animal studies often use much higher exposures relative to body weight, such as percentages of diet or high mg/kg doses, to probe mechanisms or extreme responses. These levels are not appropriate to extrapolate directly to human “supplement” doses.

Why routine supplementation is not advised
Because:

  • NDGA has a documented potential to damage liver and kidney tissue.
  • No clear threshold for a safe chronic dose has been established.
  • Preclinical benefits can often be matched or exceeded by safer strategies (diet, exercise, other approved medications or supplements).

Most clinicians and toxicologists advise against using NDGA as a self-prescribed supplement. Safer alternatives exist for goals such as antioxidant support, inflammation control, or healthy aging.

Who should absolutely avoid NDGA

  • Anyone with existing liver disease (hepatitis, cirrhosis, fatty liver) or abnormal liver tests.
  • Anyone with kidney disease, reduced kidney function, or a history of renal cysts.
  • Pregnant or breastfeeding individuals.
  • Children and adolescents.
  • People taking medications that stress the liver or kidneys (for example, certain chemotherapy agents, high-dose acetaminophen, or nephrotoxic antibiotics).
  • Individuals with bleeding disorders or on anticoagulant therapy, given signals of bleeding risk in animal lifespan studies.

Even for people without these risk factors, NDGA use outside of a formal clinical trial offers little proven benefit relative to its potential for harm.

Back to top ↑

Research summary and practical takeaways

NDGA is a striking example of a compound that sits at the intersection of herbal medicine, food science, toxicology, and modern drug development. The research narrative shows both scientific promise and clear safety warnings.

On the positive side, NDGA has helped scientists understand several fundamental pathways:

  • How lipoxygenase inhibition shapes inflammatory responses.
  • How Nrf2-mediated antioxidant defenses can be modulated by small molecules.
  • How epigenetic regulators such as p300 influence autophagy, aging, and cellular resilience.
  • How growth factor signaling pathways like IGF-1R and HER2 can be targeted in cancer models.

NDGA’s ability to extend lifespan in animal models and to influence a wide range of disease-relevant pathways has spurred interest in developing safer analogues and using it as a tool compound to map cellular networks.

On the negative side, long-term toxicity is a persistent concern. Animal data show kidney cysts and liver damage at doses not far above those used for experimental benefits. Human case reports of chaparral-associated liver injury reinforce that these are not purely theoretical risks. Historical experience as a food antioxidant ended with withdrawal due to safety questions, and regulatory bodies have not granted NDGA a modern role as a routine additive.

When interpreting NDGA research as a reader or health consumer, a few practical guidelines help:

  1. Distinguish between NDGA and its derivatives. Some derivatives are being developed as drugs with their own dosing and safety profiles, which may not apply to NDGA itself.
  2. Remember that strong preclinical effects do not guarantee safe or effective human therapies, especially when toxicity is a known issue.
  3. Question any marketing that presents NDGA or chaparral products as simple “antioxidant” or “longevity” supplements; such claims usually overlook the toxicology literature.
  4. Focus on interventions with well-characterized safety and human efficacy for goals like healthy aging, metabolic health, or inflammation control.

For most people, NDGA is best viewed as a research tool and a cautionary tale rather than a supplement to take.

Back to top ↑

References

Disclaimer

The information in this article is for general educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Nordihydroguaiaretic acid is a biologically active compound with significant toxicity concerns, and it should not be used as a self-prescribed supplement. Always consult a qualified healthcare professional before starting, stopping, or changing any medication, supplement, or health-related practice, especially if you have existing medical conditions or take prescription drugs.

If you found this guide helpful, you are welcome to share it on Facebook, X (formerly Twitter), or any other platform you prefer, and to follow our work on social media. Your support in sharing our articles helps our team continue producing careful, evidence-informed health content.

RELATED ARTICLESMORE FROM AUTHOR